Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Roifman

Showing results (221-230 of 225) with videos related to

Pageof 23
Sort By:
You have reached the last page of results.This site can display upto 225 results.
Gastroenterology|February 3, 2016
Variants in TRIM22 That Affect NOD2 Signaling Are Associated With Very-Early-Onset Inflammatory Bowel DiseaseQi Li, Cheng Hiang Lee, Lauren A Peters, et al.
Journal of Human Immunity|October 27, 2025
Improved outcome of HSCT in STAT1 gain-of-function disease following JAK inhibition bridgingEmilie Pauline Buddingh, Mary Slatter, Juan Carlos Aldave Becerra, et al.
The Journal of Allergy and Clinical Immunology|October 5, 2016
Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantationM Teresa de la Morena, David Leonard, Troy R Torgerson, et al.
The Journal of Allergy and Clinical Immunology|April 13, 2020
Characterization of the clinical and immunologic phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutationsTiziana Lorenzini, Manfred Fliegauf, Nils Klammer, et al.
Nature|November 8, 2023
Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiencyTom Le Voyer, Audrey V Parent, Xian Liu, et al.
Pageof 23

Showing results (221-230 of 225) with videos related to

Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 225 results.
Gastroenterology|February 3, 2016
Variants in TRIM22 That Affect NOD2 Signaling Are Associated With Very-Early-Onset Inflammatory Bowel DiseaseQi Li, Cheng Hiang Lee, Lauren A Peters, et al.
Journal of Human Immunity|October 27, 2025
Improved outcome of HSCT in STAT1 gain-of-function disease following JAK inhibition bridgingEmilie Pauline Buddingh, Mary Slatter, Juan Carlos Aldave Becerra, et al.
The Journal of Allergy and Clinical Immunology|October 5, 2016
Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantationM Teresa de la Morena, David Leonard, Troy R Torgerson, et al.
The Journal of Allergy and Clinical Immunology|April 13, 2020
Characterization of the clinical and immunologic phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutationsTiziana Lorenzini, Manfred Fliegauf, Nils Klammer, et al.
Nature|November 8, 2023
Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiencyTom Le Voyer, Audrey V Parent, Xian Liu, et al.
Pageof 23